A Clinical Trial Evaluating the Safety of Combining Lutathera(R) and Azedra(R) to Treat Mid-gut Neuroendocrine Tumors

Clinical trial NCT04614766 · WITHDRAWN

Trial details

NCT number: NCT04614766
Sponsor: David Bushnell
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gastro-enteropancreatic Neuroendocrine Tumor Neuroendocrine Tumors

Start date: 2022-09-30
Primary completion: 2024-04-23
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.